Certara vs Omnicell
Omnicell reported revenue of $1.2 billion in fiscal 2025, 2.8 times Certara's $419 million in fiscal 2025. Certara's revenue grew 8.8% in its latest year, and Omnicell's grew 6.5%. Certara had an operating margin of 5.0%, against 0.4% at Omnicell. Free cash flow was $95 million at Certara and $87 million at Omnicell.
Side by side
| Certara | Omnicell | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $419M | $1.2B |
| Revenue growth | 8.8% | 6.5% |
| Revenue growth a year, last 5 years | 11.5% | 5.8% |
| Gross margin | — | 42.5% |
| Operating margin | 5.0% | 0.4% |
| Net margin | −0.4% | 0.2% |
| Free cash flow | $95M | $87M |
| Free cash flow margin | 22.6% | 7.3% |
| Return on capital | 0.9% | 0.2% |
| Net debt to EBITDA | 1.1x | −0.3x |
| Dividends and buybacks | $43M | $78M |
| Change in diluted share count | 0.0% | 0.2% |
| Last close | $12.05 | $37.34 |
| P/E at the last close | — | 38.9× |
| Insider trades, last 12 months | bought $200,000, sold $0 | sold $3.0 million |
| Piotroski F-score | 5 of 8 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CertaraOmnicell
Operating margin
Percent of revenue
CertaraOmnicell
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CertaraOmnicell